Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05369936
Other study ID # EA/3006/20018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 12, 2018
Est. completion date January 30, 2021

Study information

Verified date May 2022
Source Qassim University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the objective of this study is to evaluate the ability of olfaction in obtaining positive emotional and behavioral responses toward dental anxiety and pain in patients undergoing different dental procedures.


Description:

All patients who meet inclusion criteria of the study will be given a written consent and enrolled into a randomized double-blinded controlled study (investigator and patients are blinded about the study). Patients will be divided into lavender and control groups. Patients in lavender group will subjected 2 % lavender vapors. In control group, patients will inhale distal water vapors


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date January 30, 2021
Est. primary completion date April 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 25 Years
Eligibility Inclusion Criteria: 1. Adult females over 18 years, 2. Attending morning sessions of clinics (9 am) 3. Liable for administration of local anesthesia, tooth preparation either for filling procedures or crown preparations, endodontic treatment, teeth extraction, or subgingival scaling Exclusion Criteria: 1. Males 2. Females who had allergies, bronchial asthma, common cold, pulmonary diseases, migraine, or taking antidepressants, anxiolytic drugs, opioids, or other medications that affect our results

Study Design


Intervention

Other:
Aromatherapy
Lavender will be inhaled through three phases
Placebo
Vapors of the distal water will be inhaled through three phases

Locations

Country Name City State
Saudi Arabia Ghada Amin Khalifa Buraidah Buraydah

Sponsors (1)

Lead Sponsor Collaborator
Qassim University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety score This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety 20 minutes before exposure to vapors
Primary Anxiety score This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety 20 minutes After exposure to vapors
Primary Anxiety score This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety 24 hours After exposure to vapors
Secondary Pain Score A person rates their pain on a scale of 0 to 10 Zero means "no pain,"
1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
20 minutes before exposure to vapors
Secondary Pain Score A person rates their pain on a scale of 0 to 10 Zero means "no pain,"
1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
20 minutes after exposure to vapors
Secondary Pain Score A person rates their pain on a scale of 0 to 10 Zero means "no pain,"
1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
24 hours after exposure to vapors
See also
  Status Clinical Trial Phase
Completed NCT06385314 - A Cross Sectional Study on Dental Anxiety and State Anxiety Related to Removal of Fixed Partial Dentures
Completed NCT04308005 - Drawing as a Measurement of Dental Anxiety
Completed NCT01908127 - Efficacy of Film Modelling in Paediatric Dentistry N/A
Completed NCT00695630 - Flumazenil Reversal of Oral Triazolam Phase 1/Phase 2
Completed NCT05759286 - A Blend of Lavender-neroli Oils Aromatherapy and Music for Managing Anxiety in a Pediatric Patient N/A
Completed NCT04234737 - Efficacy of Hypnotherapy in Children With Dental Anxiety N/A
Completed NCT03838081 - Evaluation on the Anxiety of Third Molar Extraction N/A
Enrolling by invitation NCT06057090 - Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients? N/A
Not yet recruiting NCT04924452 - Er:YAG Laser Therapy in Combination With Behaviour Management Technique in Reducing Anxiety Among Paediatric Patients N/A
Completed NCT03722771 - Influence of Lavender Oil on Vital Signs in Oral Surgery Patients N/A
Completed NCT03596255 - Clinical Estimation of Dental Anxiety
Completed NCT05038540 - The Effect of Virtual Reality Glasses on Dental Anxiety Control N/A
Completed NCT03324347 - Dog-Assisted Therapy in Dentistry N/A
Not yet recruiting NCT06139640 - The Effect of Damask Rose Essential Oil Aromatherapy on Dental Anxiety and Pain on Children N/A
Completed NCT02591797 - Effectiveness of Hand/Eyes/Mouth Behavior Management Technique During Local Anesthesia in Preschool Children N/A
Completed NCT02588079 - Internet-Based Cognitive Behavioral Therapy for Children With Dental Anxiety N/A
Not yet recruiting NCT00355693 - Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients Phase 4
Recruiting NCT06243705 - Effectiveness of Robot-pets in Reducing Dental Anxiety in Children N/A
Recruiting NCT06058533 - Pre-Visit Positive Imagery in Reducing Dental Anxiety N/A
Completed NCT03993080 - Virtual Reality Relaxation to Decrease Dental Anxiety N/A